Chicago, ILNCT03487185Now EnrollingIRB Ready

Obstructive Sleep Apnea of Adult Clinical Trial in Chicago, IL

Access cutting-edge obstructive sleep apnea of adult treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by The George Washington University Biostatistics Center

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access obstructive sleep apnea of adult specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obstructive sleep apnea of adult treatment provided free

Apply for This Chicago Location

Check if you qualify for this obstructive sleep apnea of adult clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Obstructive Sleep Apnea of Adult Study in Chicago

A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate of hypertensive disorders of pregnancy.

Sponsor: The George Washington University Biostatistics Center

Who Can Participate

Inclusion Criteria

Singleton gestation. Twin gestation reduced to singleton, either spontaneously or therapeutically, is not eligible unless the reduction occurred before 14 weeks project gestational age.
Gestational age at randomization between 14 weeks 0 days and 21 weeks 6 days based on clinical information and evaluation of the earliest ultrasound.
Diagnosis with mild to moderate OSA as defined by an AHI score ≥ 5 and \<30.

Exclusion Criteria

Previously prescribed, current or planned therapy for sleep apnea.
Age \< 18 years, because the rate of sleep apnea in this population is extremely low.
Inability to sleep in a stable place with access to the CPAP machine at least 5 nights per week.
Asthma requiring systemic steroid therapy for more than 14 days within the past 6 months because this population is expected to be unresponsive to CPAP therapy.
Current use of prescribed sleeping pills for insomnia.
Chronic medical conditions requiring oxygen supplementation (e.g. pulmonary fibrosis, pulmonary hypertension, cystic fibrosis) because this population is expected to be unresponsive to CPAP therapy.
Chronic renal disease with serum creatinine \>1.3 mg/dL because the primary outcome would be pre-determined.
Antiphospholipid antibody syndrome, because it would compromise the primary outcome diagnosis.
History of medical complications such as:
Active liver disease (acute hepatitis, chronic active hepatitis, persistently abnormal liver enzymes)
Thrombocytopenia with platelet count \<100,000 because of the difficulty in assessing the primary outcome.
Active vaginal bleeding (more than spotting) at the time of randomization.
Known chromosomal, genetic, major malformations or fetal demise, or planned termination of pregnancy because inclusion would compromise evaluation of secondary neonatal outcomes.
Known major uterine malformations associated with adverse pregnancy outcomes.
Current use of opiates (heroin, methadone, or other daily opioid use) due to inaccuracy of the home sleep test and inefficiency of CPAP.
Active drug use, alcohol use, or unstable psychiatric condition.
Participation in another interventional study that influences preeclampsia, hypertensive disorders of pregnancy, or GDM.
Prenatal care or delivery planned at a non-network center where access to the complete electronic medical record will not be available to research staff.
Participation in this trial in a previous pregnancy. Patients who were screened in a previous pregnancy, but not randomized, may be included.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT03487185) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obstructive Sleep Apnea of Adult Treatment Options in Chicago, IL

If you're searching for obstructive sleep apnea of adult treatment options in Chicago, IL, this clinical trial (NCT03487185) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obstructive sleep apnea of adult specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obstructive sleep apnea of adult clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Chicago, IL

See all alzheimers disease clinical trials recruiting in Chicago — not just this study.

Browse Alzheimers Disease Trials in Chicago →

Browse More Trials by Condition

Alzheimers Disease TrialsLupus TrialsUlcerative Colitis TrialsSleep Apnea TrialsAtopic Dermatitis TrialsPrurigo Nodularis TrialsSystemic Lupus Erythematosus TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL